• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchInternational Stem Cell
    Picture of International Stem Cell logo

    ISCO — International Stem Cell Share News

    $0.150.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    • Market Cap
      $1.20m
    • Enterprise Value
      $3.37m
    • Revenue
      $9.10m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ISCO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ISCO Dividends
    • Bayer says Parkinson's stem cell therapy improves symptoms in initial trial

      28/08/2023 07:00
    • Brief: International Stem Cell Corp posts positive interim clinical results for Parkinson's disease clinical trial

      13/11/2017 13:30
    • Brief: International Stem Cell to expand its revenue generating biomedical businesses

      26/09/2017 13:30
    • Brief: International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson's disease

      09/05/2017 13:30
    • Brief: International Stem Cell Q3 revenue falls 9 pct to $1.94 mln

      16/11/2016 13:30
    • Brief: International Stem Cell files for resale of up to 116.3 mln shares

      16/01/2015 22:30
    • EU's top court opens door to some stem cell patents (updated)

      18/12/2014 09:59
    • EU's top court opens door to some stem cell patents

      18/12/2014 08:53

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.